CANNAPHARMARX, INC. Proceeds from Sale of Equity Method Investments
CANNAPHARMARX, INC. (CPMD) reported Proceeds from Sale of Equity Method Investments of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfEquityMethodInvestments · last filed 2025-04-10
- CANNAPHARMARX, INC. proceeds from sale of equity method investments for the quarter ending 2024-12-31 was $0.00.
- CANNAPHARMARX, INC. proceeds from sale of equity method investments for the quarter ending 2023-12-31 was $0.00.
- CANNAPHARMARX, INC. proceeds from sale of equity method investments for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- CANNAPHARMARX, INC. proceeds from sale of equity method investments for fiscal 2023 was $78.76K.
| Period end | Proceeds from Sale of Equity Method Investments 3 month | Proceeds from Sale of Equity Method Investments 9 month | Proceeds from Sale of Equity Method Investments 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-10 | $0.00 10-K · filed 2025-04-10 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-10 | $78.76K 10-K · filed 2025-04-10 | |
| 2023-09-30 | $78.76K 10-Q · filed 2024-11-14 |